niacin and mk 0354
niacin has been researched along with mk 0354 in 5 studies
Research
Studies (5)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Behan, DP; Boatman, PD; Cai, TQ; Carballo-Jane, E; Chen, R; Cheng, K; Cherrier, MC; Colletti, SL; Connolly, DT; Gharbaoui, T; Jung, JK; Richman, JG; Sage, CR; Schrader, TO; Semple, G; Shin, YJ; Skinner, PJ; Taggart, AK; Tamura, SY; Tata, JR; Waters, MG; Webb, PJ | 1 |
Carballo-Jane, E; Chang, S; Cheng, K; Colletti, SL; Esser, C; Gerard Waters, M; Imbriglio, JE; Jung, JK; Liang, R; Raghavan, S; Schmidt, D; Schrader, TO; Smenton, A; Taggart, AK; Tata, JR; Tria, S | 1 |
Boatman, PD; Carballo-Jane, E; Chen, R; Cherrier, MC; Johnson, BR; Jung, JK; Kasem, M; Knudsen, J; Richman, JG; Sage, CR; Schrader, TO; Semple, G; Skinner, PJ; Taggart, AK; Webb, PJ; Xu, J | 1 |
Carballo-Jane, E; Chang, S; Cheng, K; Colletti, SL; Esser, C; Holt, TG; Imbriglio, JE; Jung, JK; Liang, R; Raghavan, S; Schmidt, D; Schrader, TO; Smenton, A; Taggart, AK; Tata, JR; Tria, S; Waters, MG; Wolff, MS | 1 |
Boatman, PD; Carballo-Jane, E; Caro, L; Chen, R; Cherrier, MC; Colletti, SL; Connolly, DT; Cote, J; Hammond, M; Johnson, BR; Jung, JK; Kasem, M; Knudsen, J; Lai, E; Lauring, B; Luo, WL; Richman, JG; Sage, CR; Schrader, TO; Semple, G; Skinner, P; Taggart, AK; Tata, JR; Wagner, J; Waters, MG; Webb, PJ; Xu, J | 1 |
Trials
1 trial(s) available for niacin and mk 0354
Article | Year |
---|---|
(1aR,5aR)1a,3,5,5a-Tetrahydro-1H-2,3-diaza-cyclopropa[a]pentalene-4-carboxylic acid (MK-1903): a potent GPR109a agonist that lowers free fatty acids in humans.
Topics: Animals; Fatty Acids, Nonesterified; Humans; Hypolipidemic Agents; Male; Niacin; Pyrazoles; Rats; Receptors, G-Protein-Coupled; Receptors, Nicotinic; Stereoisomerism; Vasodilator Agents | 2012 |
Other Studies
4 other study(ies) available for niacin and mk 0354
Article | Year |
---|---|
3-(1H-tetrazol-5-yl)-1,4,5,6-tetrahydro-cyclopentapyrazole (MK-0354): a partial agonist of the nicotinic acid receptor, G-protein coupled receptor 109a, with antilipolytic but no vasodilatory activity in mice.
Topics: Adipocytes; Animals; Fatty Acids, Nonesterified; Humans; Hypolipidemic Agents; Lipolysis; Male; Mice; Mice, Inbred C57BL; Pyrazoles; Receptors, G-Protein-Coupled; Receptors, Nicotinic; Tetrazoles; Vasodilation | 2008 |
GPR109a agonists. Part 1: 5-Alkyl and 5-aryl-pyrazole-tetrazoles as agonists of the human orphan G-protein coupled receptor GPR109a.
Topics: Animals; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nicotinic Agonists; Pyrazoles; Receptors, G-Protein-Coupled; Receptors, Nicotinic; Tetrazoles; Vasodilation | 2009 |
Potent tricyclic pyrazole tetrazole agonists of the nicotinic acid receptor (GPR109a).
Topics: Animals; Dogs; Haplorhini; Humans; Mice; Pyrazoles; Rats; Receptors, G-Protein-Coupled; Receptors, Nicotinic; Tetrazoles; Vasodilator Agents | 2010 |
GPR109a agonists. Part 2: pyrazole-acids as agonists of the human orphan G-protein coupled receptor GPR109a.
Topics: Animals; Fatty Acids; Humans; Mice; Niacin; Pyrazoles; Receptors, G-Protein-Coupled; Receptors, Nicotinic | 2010 |